fbpx Skip to main content

BioCommunique Article

Biocom California member Mammoth Biosciences’ CEO Trevor Martin received the prestigious 2020 Executive of the Year recognition in the field of Healthcare.

San Francisco Business Times Recognizes Mammoth Biosciences’ CEO Trevor Martin as 2020 Executive of the Year

  • 2021-01-21T21:00:00.000+0000
  • Bay Area
  • Author: Pavel Svoboda

In a year of unprecedented events, San Francisco Business Times (SFBT) capped the year off by celebrating the hard work and dedication of small business owners by bestowing the 2020 Executive of the Year title to three small business owners, leading in Commercial Real Estate, Food and Lifestyle, and Healthcare. Biocom California member Mammoth Biosciences’ CEO Trevor Martin received the prestigious 2020 Executive of the Year recognition in the field of Healthcare for the company’s pivoting their CRISPR-based diagnostic platform COVID-19 disease detection and testing, which became their DETECTR BOOST™ SARS-CoV-2.

2020 was a momentous year for Mammoth Biosciences. They closed a Series B fundraising round of $45 million at the end of January. In two weeks’ time, the team published a white paper on a protocol for rapid detection of SARS-CoV-2 using CRISPR: SARS-CoV-2 DETECTR and by mid-April, a 100 Covid patient sample was under peer review in the journal Nature Biotechnology. In the second half of 2020, Mammoth Bioscience worked with GlaxoSmithKline (GSK)to develop rapid handheld Covid tests and witnessed their co-founder and scientific advisory board chair, Dr. Jennifer Doudna, receive the 2020 Nobel Prize for Chemistry for her co-development of CRISPR-Cas9 technology.

Trevor also received a Biocom California Catalyst Award in 2020 in recognition for his outstanding work in the industry and community before turning 40 years of age.

Heading into 2021, Mammoth is working with MilliporeSigma and Hamilton Co. to commercialize their DETECTR BOOST test, and at-home COVID-19 diagnostic tests will continue to be manufactured in partnership with GSK.

To view the SFBT Healthcare 2020 Executive of the Year article, visit here.